Promising In Vivo Results in One of the Most Aggressive Forms of Ovarian Cancer
Pattern Announces Promising In Vivo Antiproliferative Activity Against High-Grade Serous Ovarian Cancer with Two Novel Drug Combinations REDMOND, WA, June 13, 2023 -- Pattern Computer®, Inc. (Pattern), a leading AI-powered technology company dedicated to advancing innovative treatments for cancer, [...]